{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-064079","form_type":"8-K","ticker":"GRDN","cik":"0001802255","company_name":"Guardian Pharmacy Services, Inc.","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.926328+00:00","generated_at":"2026-05-24T05:09:09.427052+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Guardian Pharmacy Q4 revenue up 20% to $338.6M; FY net loss $71M on IPO charges","bullets":["Q4 revenue $338.6M (+20% YoY); resident count 186,000 (+14% YoY).","Q4 net income $11.8M (down $2.7M YoY); FY net loss $71.0M on $131.5M stock-comp from IPO/Reorg.","Adjusted EBITDA Q4 $25.9M (+30% YoY); FY $90.8M (+19% YoY).","No debt outstanding at year-end; $40M credit line available (expandable to $75M).","FY2025 guidance: revenue $1.33B-$1.35B, Adj. EBITDA $97M-$101M; incl. ~$4M public co. costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-064079","json":"https://secwatch.observer/filing/0001193125-25-064079.json","markdown":"https://secwatch.observer/filing/0001193125-25-064079.md","text":"https://secwatch.observer/filing/0001193125-25-064079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/0001193125-25-064079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802255/000119312525064079/d843493d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:09:09.427052+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}